EC pharmaceutical regulatory reform plan

EU Commissioner Erkki Liikanen last week outlined the Commission's plans for reform of the EU's pharmaceutical legislation. The Commission's key proposals are the introduction of fast-track registration, conditional marketing authorization, and removal of the marketing authorization renewal procedure. For patients, the Commission wants to provide more transparency and access to data on the Internet.

In a speech before the Mentor Group

Read the full 600 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE